US Bancorp’s Sana Biotechnology SANA Stock Holding History

US Bancorp’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$373	Sell	107 -587	-85%	-$1.89K	﹤0.01%	4076
2026 Q1	$2K	Buy	694 +109	+19%	+$429	﹤0.01%	3806
2025 Q4	$2.38K	Hold	585	–	–	﹤0.01%	3729
2025 Q3	$2.08K	Sell	585 -85	-13%	-$307	﹤0.01%	3753
2025 Q2	$1.83K	Buy	670 +64	+11%	+$132	﹤0.01%	3877
2025 Q1	$1.02K	Buy	606 +68	+13%	+$190	﹤0.01%	3986
2024 Q4	$877	Sell	538 -112	-17%	-$334	﹤0.01%	3975
2024 Q3	$2.7K	Sell	650 -205	-24%	-$1.08K	﹤0.01%	3715
2024 Q2	$4.67K	Buy	855 +523	+158%	+$4.17K	﹤0.01%	3538
2024 Q1	$3.32K	Hold	332	–	–	﹤0.01%	3621
2023 Q4	$1.35K	Buy	+332	New	+$1.22K	﹤0.01%	3764
2023 Q2	–	Sell	-4,202	Closed	-$13.7K	–	4117
2023 Q1	$13.7K	Buy	+4,202	New	+$16.8K	﹤0.01%	3165
2021 Q3	–	Sell	-21	Closed	–	–	4171
2021 Q2	$0	Buy	21 +8	+62%	+$181	﹤0.01%	4063
2021 Q1	$0	Buy	+13	New	+$423	﹤0.01%	3954

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

US Bancorp's SANA Position: Q2 2026 in Review

US Bancorp reduced its Sana Biotechnology (SANA) stake by 85% in Q2 2026, selling an estimated $1.89K and leaving 107 shares worth $373. The position accounts for ﹤0.01% of the portfolio, ranked #4076.

US Bancorp first reported a position in SANA in Q1 2021 and has held it in 14 quarters since. The position peaked at $13.7K in Q1 2023. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

US Bancorp held 107 shares of Sana Biotechnology worth $373 as of Q2 2026.
US Bancorp sold 587 Sana Biotechnology shares in Q2 2026, an estimated $1.89K.
Sana Biotechnology made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4076 holding.
US Bancorp first reported a position in Sana Biotechnology in Q1 2021 and has held it in 14 quarters since.
US Bancorp's Sana Biotechnology position peaked at $13.7K in Q1 2023.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.